Skip to main content
Clinical Trials/ISRCTN76193287
ISRCTN76193287
Active, not recruiting
Phase 4

A Study of Cardiovascular Events iN Diabetes Plus (ASCEND PLUS)

niversity of Oxford0 sites20,000 target enrollmentJune 27, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Oxford
Enrollment
20000
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2022
End Date
August 17, 2048
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults aged at least 55 years
  • 2\. Type 2 diabetes mellitus

Exclusion Criteria

  • 1\. Myocardial Infarction
  • 3\. Current or planned treatment with a GLP\-1 RA
  • 4\. Previous hypersensitivity to or intolerance of GLP\-1 RA therapy
  • 5\. Severe hypoglycaemia within the last six months or during run\-in
  • 6\. Symptomatic hypoglycaemia within the last month
  • 7\. Currently under consideration to commence insulin
  • 8\. Severe heart failure (NYHA class 4\)
  • 9\. Current or planned renal replacement therapy
  • 10\. Unwilling to complete regular follow\-up assessments
  • 11\. Ongoing treatment for cancer or diagnosis with cancer (excluding non\-melanoma skin cancer) in the last 2 years

Outcomes

Primary Outcomes

Not specified

Similar Trials